Cargando…
Increased HRD score in cisplatin resistant penile cancer cells
BACKGROUND/INTRODUCTION: Penile cancer is a rare disease in demand for new therapeutic options. Frequently used combination chemotherapy with 5 fluorouracil (5-FU) and cisplatin (CDDP) in patients with metastatic penile cancer mostly results in the development of acquired drug resistance. Availabili...
Autores principales: | Winkelmann, Ria, Bankov, Katrin, Döring, Claudia, Cinatl, Jaroslav, Grothe, Sebastian, Rothweiler, Florian, Michaelis, Martin, Schmitt, Christina, Wild, Peter J., Demes, Melanie, Cinatl, Jindrich, Vallo, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789628/ https://www.ncbi.nlm.nih.gov/pubmed/36564761 http://dx.doi.org/10.1186/s12885-022-10432-7 |
Ejemplares similares
-
The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methods
por: Winkelmann, Ria, et al.
Publicado: (2022) -
Tumor-associated immune cell infiltrate density in penile squamous cell carcinomas
por: Hladek, Luca, et al.
Publicado: (2022) -
Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach
por: Sarin, Navin, et al.
Publicado: (2018) -
ABCG2 impairs the activity of the aurora kinase inhibitor tozasertib but not of alisertib
por: Michaelis, Martin, et al.
Publicado: (2015) -
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2021)